News
Archive
Novadip Biosciences SA announces positive results from Phase 1/2 clinical trial in patients with severe bone non-union of the lower limb following trauma
Ventyx Biosciences announces dosing of the first patient in the Phase 2 SERENITY trial of VTX958 for the treatment of moderate to severe plaque psoriasis
Resolve Therapeutics completes enrollment of Phase II Long Covid clinical trial
Novadip Biosciences raises additional EUR 40 Million bringing total company funding to EUR 88 Million
Phase Four unveils game changing engine for LEO Constellations
Ventyx Biosciences announces positive topline Phase I data for its selective allosteric TYK2 inhibitor VTX958
Back To News
July 23, 2019
All successful ETFs start with a good idea. But how do you know if you have a good idea?
Fuzzy Logix offers an automation tool called FastINDX to help ETF designers test drive their investment ideas. FastIndx is essentially a tool that allows someone who is in the market to design an ETF to first test out the pieces. In database analytics was created by performing the analytics directly where the data resides … Continue reading “All successful ETFs start with a good idea. But how do you know if you have a good idea?”
The post All successful ETFs start with a good idea. But how do you know if you have a good idea? appeared first on Fuzzy Logix.